EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats

Kira V Derkach iD, Alena S Pechalnova iD, Viktor N Sorokoumov iD, Inna I Zorina iD, Irina Y Morina iD, Elizaveta E Chernenko, Egor A Didenko, Irina V Romanova, Alexander O Shpakov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kira V Derkach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia. Hauptthemen laut MEDLINE: Thyroid Gland, Diabetes Mellitus, Experimental, Receptors, Thyrotropin, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The approaches to correct thyroid deficiency include replacement therapy with thyroid hormones (THs), but such therapy causes a number of side effects. A possible alternative is thyroid-stimulating hormone (TSH) receptor activators, including allosteric agonists. The aim of this work was to study the effect of ethyl-2-(4-(4-(5-amino-6-(tert-butylcarbamoyl)-2-(methylthio)thieno[2,3-d]pyrimidin-4-yl)phenyl)-1H-1,2,3-triazol-1-yl) acetate (TPY3m), a TSH receptor allosteric agonist developed by us, on basal and thyroliberin (TRH)-stimulated TH levels and the hypothalamic-pituitary-thyroid (HPT) axis in male rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes mellitus (T2DM). Single and three-day administration of TPY3m (i.p., 20 mg/kg) was studied, and the effect of TPY3m on the HPT axis was compared with that of levothyroxine. TPY3m increased TH levels when administered to both healthy and diabetic rats, normalizing thyroxine and triiodothyronine levels in T2DM and, unlike levothyroxine, without negatively affecting TSH levels or the expression of hypothalamic and pituitary genes responsible for TSH production. TPY3m pretreatment preserved the stimulatory effects of TRH on TH levels and thyroid gene expression. This indicates the absence of competition between TPY3m and endogenous TSH for TSH receptor activation and is supported by our in vitro results on TPY3m- and TSH-stimulated adenylate cyclase activity in rat thyroid membranes. Morphological analysis of thyroid glands in diabetic rats after three-day TPY3m administration shows an increase in its functional activity without destructive changes. To summarize, TPY3m, with the activity of a partial allosteric agonist of the TSH receptor, was created as a prototype of drugs to correct thyroid insufficiency in T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid GlandDiabetes Mellitus, ExperimentalReceptors, ThyrotropinDiabetes Mellitus, Type 2AnimalsMaleRatsAllosteric RegulationRats, WistarThyrotropinMolecular Weight

Stichwörter der Autor:innen

allosteric agonistdiabetes mellitushypothyroidismthyroid hormonethyroid-stimulating hormone receptorthyroliberin

Substanzen

Receptors, ThyrotropinThyrotropin

Autor:innen und Institutionen

  • Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg 194223, Russia.
  • Institute of Chemistry, St. Petersburg State University, St. Petersburg 199034, Russia.

ORCID-Profile: Kira V Derkach, Alena S Pechalnova, Viktor N Sorokoumov, Inna I Zorina, Irina Y Morina, Alexander O Shpakov

Förderung

  • Russian Science Foundation

Zitieren

APA

Derkach, K. V., Pechalnova, A. S., Sorokoumov, V. N., Zorina, I. I., Morina, I. Y., Chernenko, E. E., Didenko, E. A., Romanova, I. V., & Shpakov, A. O. (2025). Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020703

Vancouver

Derkach KV, Pechalnova AS, Sorokoumov VN, Zorina II, Morina IY, Chernenko EE, et al. Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020703

BibTeX
@article{Derkach2025,
  author = {Derkach, Kira V and Pechalnova, Alena S and Sorokoumov, Viktor N and Zorina, Inna I and Morina, Irina Y and Chernenko, Elizaveta E and Didenko, Egor A and Romanova, Irina V and Shpakov, Alexander O},
  title = {Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020703}
}
Kostenlos starten →